{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T16:09:56Z","timestamp":1779379796374,"version":"3.53.1"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V113C-039"],"award-info":[{"award-number":["V113C-039"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V113C-011"],"award-info":[{"award-number":["V113C-011"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V113C-010"],"award-info":[{"award-number":["V113C-010"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V114C-089"],"award-info":[{"award-number":["V114C-089"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V114C-064"],"award-info":[{"award-number":["V114C-064"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V114C-217"],"award-info":[{"award-number":["V114C-217"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007354","name":"Yen Tjing Ling Medical Foundation","doi-asserted-by":"publisher","award":["CI-113-32"],"award-info":[{"award-number":["CI-113-32"]}],"id":[{"id":"10.13039\/501100007354","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007354","name":"Yen Tjing Ling Medical Foundation","doi-asserted-by":"publisher","award":["CI-113-30"],"award-info":[{"award-number":["CI-113-30"]}],"id":[{"id":"10.13039\/501100007354","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007354","name":"Yen Tjing Ling Medical Foundation","doi-asserted-by":"publisher","award":["CI-114-35"],"award-info":[{"award-number":["CI-114-35"]}],"id":[{"id":"10.13039\/501100007354","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Kun-Po Soo Medical Foundation, Ministry of Science and Technology, Taiwan","award":["MOST110-2314-B-075-026"],"award-info":[{"award-number":["MOST110-2314-B-075-026"]}]},{"name":"Kun-Po Soo Medical Foundation, Ministry of Science and Technology, Taiwan","award":["MOST110-2314-B-075-024 -MY3"],"award-info":[{"award-number":["MOST110-2314-B-075-024 -MY3"]}]},{"name":"Kun-Po Soo Medical Foundation, Ministry of Science and Technology, Taiwan","award":["MOST 109-2314-B-010-050-MY3"],"award-info":[{"award-number":["MOST 109-2314-B-010-050-MY3"]}]},{"name":"Kun-Po Soo Medical Foundation, Ministry of Science and Technology, Taiwan","award":["MOST111-2314-B-075 -014 -MY2"],"award-info":[{"award-number":["MOST111-2314-B-075 -014 -MY2"]}]},{"name":"Kun-Po Soo Medical Foundation, Ministry of Science and Technology, Taiwan","award":["MOST 111-2314-B-075 -013"],"award-info":[{"award-number":["MOST 111-2314-B-075 -013"]}]},{"name":"Kun-Po Soo Medical Foundation, Ministry of Science and Technology, Taiwan","award":["NSTC113-2314-B-075-042"],"award-info":[{"award-number":["NSTC113-2314-B-075-042"]}]},{"name":"Kun-Po Soo Medical Foundation, Ministry of Science and Technology, Taiwan","award":["NSTC114-2628-B-A49 -008 -MY3"],"award-info":[{"award-number":["NSTC114-2628-B-A49 -008 -MY3"]}]},{"name":"Kun-Po Soo Medical Foundation, Ministry of Science and Technology, Taiwan","award":["NSTC114-2314-B-075-022"],"award-info":[{"award-number":["NSTC114-2314-B-075-022"]}]},{"name":"Kun-Po Soo Medical Foundation, Ministry of Science and Technology, Taiwan","award":["NSTC114-2314-B-075-023"],"award-info":[{"award-number":["NSTC114-2314-B-075-023"]}]},{"name":"Taipei, Taichung, Kaohsiung Veterans General Hospital"},{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Academia Sinica Joint Research Program","award":["VTA112-V1-6-1"],"award-info":[{"award-number":["VTA112-V1-6-1"]}]},{"name":"Academia Sinica Joint Research Program","award":["VTA114-V1-4-1"],"award-info":[{"award-number":["VTA114-V1-4-1"]}]},{"name":"Veterans General Hospitals and University System of Taiwan Joint Research Program","award":["VGHUST112-G1-8-1"],"award-info":[{"award-number":["VGHUST112-G1-8-1"]}]},{"name":"Veterans General Hospitals and University System of Taiwan Joint Research Program","award":["VGHUST114-G1-9-1"],"award-info":[{"award-number":["VGHUST114-G1-9-1"]}]},{"DOI":"10.13039\/501100005937","name":"Cheng Hsin General Hospital","doi-asserted-by":"crossref","award":["CY11402-1"],"award-info":[{"award-number":["CY11402-1"]}],"id":[{"id":"10.13039\/501100005937","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005937","name":"Cheng Hsin General Hospital","doi-asserted-by":"crossref","award":["CY11402-2"],"award-info":[{"award-number":["CY11402-2"]}],"id":[{"id":"10.13039\/501100005937","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Intravenous ketamine demonstrates rapid efficacy for treatment-resistant depression (TRD). However, its impact on individual depressive symptoms and whether the degree of treatment resistance moderates these effects remain unclear. This study aimed to dissect symptom-specific trajectories and examine the moderating role of the degree of treatment resistance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a post-hoc analysis of pooled data from two randomized, double-blind, controlled trials involving 154 adults with TRD receiving subanesthetic ketamine or control. Depressive symptoms were assessed using the Montgomery-\u00c5sberg Depression Rating Scale (MADRS) over 15\u00a0days. Linear mixed-effect models (LMM) analyzed total scores, while generalized estimating equations (GEE) assessed item-level improvement. The Maudsley Staging Method (MSM) was used to quantify the degree of treatment resistance and evaluate its moderating effect.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Ketamine elicited a significant reduction in MADRS total scores (P\u2009&amp;lt;\u2009.001). Item-level analysis revealed significant improvements in seven symptoms, including apparent sadness, inner tension, and suicidal thoughts (P\u2009&amp;lt;\u2009.05). Crucially, a significant treatment \u00d7 MSM interaction was found for apparent sadness (P\u2009=\u2009.002) and inner tension (P\u2009=\u2009.024), indicating attenuated efficacy in patients with higher resistance. Conversely, anti-suicidal efficacy was robust and not significantly moderated by resistance severity (P\u2009=\u2009.083).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Ketamine demonstrates broad efficacy in TRD but may exhibit symptom-specific divergence: anti-suicidal effects appear robust across resistance levels, whereas improvements in apparent sadness and inner tension may be attenuated by greater resistance severity. These exploratory findings warrant confirmation in prospective studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>UMIN Clinical Trials Registry (UMIN-CTR): Registration number: UMIN000016985 (registered June 30, 2016), UMIN000023581 (registered December 31, 2018), and UMIN000033916 (registered November 30, 2021).<\/jats:p>\n                    <jats:p>Significant outcomes 1) Intravenous ketamine showed rapid anti-suicidal efficacy in patients with treatment-resistant depression (TRD), which was not significantly moderated by the baseline severity of treatment resistance. 2) Improvement in apparent sadness and inner tension was significantly moderated by the degree of treatment resistance, with attenuated efficacy observed in patients with higher Maudsley Staging Method (MSM) scores. 3) These exploratory findings raise the hypothesis that a symptom-specific stratified therapeutic approach may be warranted. Future research should examine whether ketamine could serve as an acute intervention for suicidal crises across the resistance spectrum, and whether improvements in specific affective symptoms may require augmentation strategies in highly refractory cases. Limitations 1) Limited generalizability: The study population consisted exclusively of Han Chinese patients from a single medical center, which may restrict the applicability of these symptom-specific findings to other ethnic groups or cultural contexts, given potential genetic and cultural variations. 2) Methodological constraints: This was a post-hoc analysis of pooled data with a heterogeneous control group (saline or midazolam). Functional unblinding may have occurred in both treatment directions, and formal blinding assessment was not conducted in either contributing trial. Sensitivity analyses adjusting for study source confirmed the robustness of all primary findings. 3) Study design duration: The protocol involved a single infusion with a short 15-day follow-up period, precluding conclusions regarding the long-term durability of the observed symptom divergence or the efficacy of repeated dosing regimens.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ijnp\/pyag021","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:02:28Z","timestamp":1777554148000},"source":"Crossref","is-referenced-by-count":0,"title":["Distinct therapeutic profiles of ketamine in treatment-resistant depression: an exploratory analysis"],"prefix":"10.1093","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-4224-2466","authenticated-orcid":false,"given":"Kuan-I","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Taipei Veterans General Hospital , Taipei ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Chen","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Taipei Veterans General Hospital , Taipei ,","place":["Taiwan"]},{"name":"Division of Psychiatry, Faculty of Medicine, National Yang Ming Chiao Tung University , Taipei ,","place":["Taiwan"]},{"name":"Institute of Brain Science, College of Medicine, National Yang Ming Chiao Tung University , Taipei ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0670-1153","authenticated-orcid":false,"given":"Cheng-Ta","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Taipei Veterans General Hospital , Taipei ,","place":["Taiwan"]},{"name":"Division of Psychiatry, Faculty of Medicine, National Yang Ming Chiao Tung University , Taipei ,","place":["Taiwan"]},{"name":"Institute of Brain Science, College of Medicine, National Yang Ming Chiao Tung University , Taipei ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Mei","family":"Bai","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Taipei Veterans General Hospital , Taipei ,","place":["Taiwan"]},{"name":"Division of Psychiatry, Faculty of Medicine, National Yang Ming Chiao Tung University , Taipei ,","place":["Taiwan"]},{"name":"Institute of Brain Science, College of Medicine, National Yang Ming Chiao Tung University , Taipei ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tung-Ping","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Taipei Veterans General Hospital , Taipei ,","place":["Taiwan"]},{"name":"Division of Psychiatry, Faculty of Medicine, National Yang Ming Chiao Tung University , Taipei ,","place":["Taiwan"]},{"name":"Institute of Brain Science, College of Medicine, National Yang Ming Chiao Tung University , Taipei ,","place":["Taiwan"]},{"name":"Department of Psychiatry, Cheng Hsin General Hospital , Taipei ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6516-1073","authenticated-orcid":false,"given":"Mu-Hong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Taipei Veterans General Hospital , Taipei ,","place":["Taiwan"]},{"name":"Division of Psychiatry, Faculty of Medicine, National Yang Ming Chiao Tung University , Taipei ,","place":["Taiwan"]},{"name":"Institute of Brain Science, College of Medicine, National Yang Ming Chiao Tung University , Taipei ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"2026052111521042300_ref1","doi-asserted-by":"publisher","first-page":"120018","DOI":"10.1016\/j.jad.2025.120018","article-title":"Global, regional, and national burden of depression, 1990\u20132021: a decomposition and age-period-cohort analysis with projection to 2040","volume":"391","author":"Xu","year":"2025","journal-title":"J Affect Disord"},{"key":"2026052111521042300_ref2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/wps.21120","article-title":"Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions","volume":"22","author":"McIntyre","year":"2023","journal-title":"World Psychiatry"},{"key":"2026052111521042300_ref3","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jad.2018.06.045","article-title":"The burden of treatment-resistant depression: a systematic review of the economic and quality of life literature","volume":"242","author":"Johnston","year":"2019","journal-title":"J Affect Disord"},{"key":"2026052111521042300_ref4","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.jpsychires.2024.11.022","article-title":"Health-care utilisation and associated economic burden in major depressive disorder and treatment-resistant depression in a longitudinal population-based cohort study of 110.000 patients","volume":"180","author":"Pappa","year":"2024","journal-title":"J Psychiatr Res"},{"key":"2026052111521042300_ref5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1001\/jamapsychiatry.2022.3860","article-title":"Association of treatment-resistant depression with patient outcomes and health care resource utilization in a population-wide study","volume":"80","author":"Lundberg","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"2026052111521042300_ref6","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1016\/S0140-6736(18)31948-2","article-title":"Depression","volume":"392","author":"Malhi","year":"2018","journal-title":"Lancet"},{"key":"2026052111521042300_ref7","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"2026052111521042300_ref8","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1176\/appi.ajp.2018.18020138","article-title":"Attenuation of antidepressant effects of ketamine by opioid receptor antagonism","volume":"175","author":"Williams","year":"2018","journal-title":"Am J Psychiatry"},{"key":"2026052111521042300_ref9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1176\/appi.ajp.20240378","article-title":"Redefining ketamine pharmacology for antidepressant action: synergistic NMDA and opioid receptor interactions?","volume":"182","author":"Levinstein","year":"2025","journal-title":"Am J Psychiatry"},{"key":"2026052111521042300_ref10","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1038\/s41591-025-03800-w","article-title":"Effect of naltrexone pretreatment on ketamine-induced glutamatergic activity and symptoms of depression: a randomized crossover study","volume":"31","author":"Jelen","year":"2025","journal-title":"Nat Med"},{"key":"2026052111521042300_ref11","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyaf073","article-title":"Methodological considerations for interpreting ketamine-naltrexone trials in depression","volume":"28","author":"Bandeira","year":"2025","journal-title":"Int J Neuropsychopharmacol"},{"key":"2026052111521042300_ref12","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1038\/npp.2017.94","article-title":"Dose-related effects of adjunctive ketamine in Taiwanese patients with treatment-resistant depression","volume":"42","author":"Su","year":"2017","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol"},{"key":"2026052111521042300_ref13","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1093\/ijnp\/pyad014","article-title":"A randomized, double-blind, midazolam-controlled trial of low-dose ketamine infusion in patients with treatment-resistant depression and prominent suicidal ideation","volume":"26","author":"Su","year":"2023","journal-title":"Int J Neuropsychopharmacol"},{"key":"2026052111521042300_ref14","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"key":"2026052111521042300_ref15","doi-asserted-by":"publisher","first-page":"e0229381","DOI":"10.1371\/journal.pone.0229381","article-title":"Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg depression rating scale, the gold standard clinician rating scale: a meta-analysis of randomised placebo-controlled trials","volume":"15","author":"Hengartner","year":"2020","journal-title":"PLoS One"},{"key":"2026052111521042300_ref16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/mpr.1388","article-title":"The structure of the Montgomery\u2013\u00c5sberg depression rating scale over the course of treatment for depression","volume":"22","author":"Quilty","year":"2013","journal-title":"Int J Methods Psychiatr Res"},{"key":"2026052111521042300_ref17","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1001\/jamapsychiatry.2017.0025","article-title":"Reevaluating the efficacy and predictability of antidepressant treatments: a symptom clustering approach","volume":"74","author":"Chekroud","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"2026052111521042300_ref18","doi-asserted-by":"publisher","first-page":"952","DOI":"10.4088\/JCP.08m04728","article-title":"The Maudsley staging method for treatment-resistant depression: prediction of longer-term outcome and persistence of symptoms","volume":"70","author":"Fekadu","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"2026052111521042300_ref19","doi-asserted-by":"publisher","first-page":"e2836","DOI":"10.1002\/hup.2836","article-title":"Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment-resistant depression","volume":"37","author":"Jesus-Nunes","year":"2022","journal-title":"Hum Psychopharmacol"},{"key":"2026052111521042300_ref20","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.jpsychires.2022.04.037","article-title":"Real-world effectiveness of ketamine in treatment-resistant depression: a systematic review & meta-analysis","volume":"151","author":"Alnefeesi","year":"2022","journal-title":"J Psychiatr Res"},{"key":"2026052111521042300_ref21","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1038\/s41386-019-0480-y","article-title":"Maintenance of antidepressant and antisuicidal effects by D-cycloserine among patients with treatment-resistant depression who responded to low-dose ketamine infusion: a double-blind randomized placebo-control study","volume":"44","author":"Chen","year":"2019","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol"},{"key":"2026052111521042300_ref22","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/bdi.70048","article-title":"Defining treatment-resistant bipolar depression: recommendations from the ISBD task force","volume":"27","author":"Vieta","year":"2025","journal-title":"Bipolar Disord"},{"key":"2026052111521042300_ref23","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.4088\/JCP.15m10253","article-title":"Evidence to support Montgomery-Asberg depression rating scale administration every 24 hours to assess rapid onset of treatment response","volume":"77","author":"Johnson","year":"2016","journal-title":"J Clin Psychiatry"},{"key":"2026052111521042300_ref24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/YIC.0b013e32832a8eb2","article-title":"Is the significant superiority of escitalopram compared with other antidepressants clinically relevant?","volume":"24","author":"Montgomery","year":"2009","journal-title":"Int Clin Psychopharmacol"},{"key":"2026052111521042300_ref25","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s40263-022-00916-2","article-title":"Evaluation of individual items of the patient health questionnaire (PHQ-9) and Montgomery-Asberg depression rating scale (MADRS) in adults with treatment-resistant depression treated with Esketamine nasal spray combined with a new oral antidepressant","volume":"36","author":"Floden","year":"2022","journal-title":"CNS Drugs"},{"key":"2026052111521042300_ref26","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.jad.2020.09.071","article-title":"Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis","volume":"278","author":"Bahji","year":"2021","journal-title":"J Affect Disord"},{"key":"2026052111521042300_ref27","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1097\/JCP.0000000000002060","article-title":"Efficacy of intravenous racemic ketamine on global severity and individual symptoms of depression: an exploratory retrospective analysis","volume":"45","author":"Landrum","year":"2025","journal-title":"J Clin Psychopharmacol"},{"key":"2026052111521042300_ref28","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1176\/appi.ajp.2017.17040472","article-title":"The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis","volume":"175","author":"Wilkinson","year":"2018","journal-title":"Am J Psychiatry"},{"key":"2026052111521042300_ref29","doi-asserted-by":"publisher","first-page":"116282","DOI":"10.1016\/j.psychres.2024.116282","article-title":"Effect of intravenous ketamine on suicidality in adults with treatment-resistant depression: a real world effectiveness study","volume":"343","author":"Chen-Li","year":"2025","journal-title":"Psychiatry Res"},{"key":"2026052111521042300_ref30","doi-asserted-by":"publisher","first-page":"e067194","DOI":"10.1136\/bmj-2021-067194","article-title":"Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial","volume":"376","author":"Abbar","year":"2022","journal-title":"BMJ."},{"key":"2026052111521042300_ref31","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jad.2023.03.064","article-title":"Treatment response with ketamine in chronic suicidality: an open label functional connectivity study","volume":"331","author":"Can","year":"2023","journal-title":"J Affect Disord"},{"key":"2026052111521042300_ref32","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/pcn.13572","article-title":"Insights into the neurobiology of suicidality: explicating the role of glutamatergic systems through the lens of ketamine","volume":"77","author":"Can","year":"2023","journal-title":"Psychiatry Clin Neurosci"},{"key":"2026052111521042300_ref33","doi-asserted-by":"publisher","first-page":"416","DOI":"10.7326\/ANNALS-24-01938","article-title":"Assessment and Management of Patients at risk for suicide: synopsis of the 2024 U.S. Department of Veterans Affairs and U.S. Department of Defense clinical practice guidelines","volume":"178","author":"Brenner","year":"2025","journal-title":"Ann Intern Med"},{"key":"2026052111521042300_ref34","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s41467-019-09562-7","article-title":"Lower synaptic density is associated with depression severity and network alterations","volume":"10","author":"Holmes","year":"2019","journal-title":"Nat Commun"},{"key":"2026052111521042300_ref35","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1126\/science.1222939","article-title":"Synaptic dysfunction in depression: potential therapeutic targets","volume":"338","author":"Duman","year":"2012","journal-title":"Science."},{"key":"2026052111521042300_ref36","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1038\/s41380-022-01465-2","article-title":"Imaging the effect of ketamine on synaptic density (SV2A) in the living brain","volume":"27","author":"Holmes","year":"2022","journal-title":"Mol Psychiatry"},{"key":"2026052111521042300_ref37","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jad.2022.12.021","article-title":"Biomarkers of ketamine\u2019s antidepressant effect: an umbrella review","volume":"323","author":"Meshkat","year":"2023","journal-title":"J Affect Disord"},{"key":"2026052111521042300_ref38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.euroneuro.2023.05.009","article-title":"Immune-related biomarkers and suicidal behaviors: a meta-analysis","volume":"75","author":"Neupane","year":"2023","journal-title":"Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol"},{"key":"2026052111521042300_ref39","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/acps.13351","article-title":"Increased C-reactive protein concentration and suicidal behavior in people with psychiatric disorders: a systematic review and meta-analysis","volume":"144","author":"Miola","year":"2021","journal-title":"Acta Psychiatr Scand"},{"key":"2026052111521042300_ref40","doi-asserted-by":"publisher","first-page":"109299","DOI":"10.1016\/j.neuropharm.2022.109299","article-title":"The therapeutic role of ketamine and esketamine in treating psychopathological domains of depression","volume":"223","author":"Jawad","year":"2023","journal-title":"Neuropharmacology."},{"key":"2026052111521042300_ref41","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.ygeno.2020.12.030","article-title":"Treatment response to low-dose ketamine infusion for treatment-resistant depression: a gene-based genome-wide association study","volume":"113","author":"Chen","year":"2021","journal-title":"Genomics."},{"key":"2026052111521042300_ref42","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jad.2016.06.062","article-title":"An item response theory evaluation of the young mania rating scale and the Montgomery-Asberg depression rating scale in the systematic treatment enhancement program for bipolar disorder (STEP-BD)","volume":"205","author":"Prisciandaro","year":"2016","journal-title":"J Affect Disord"}],"container-title":["International Journal of Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ijnp\/advance-article-pdf\/doi\/10.1093\/ijnp\/pyag021\/68194209\/pyag021.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ijnp\/article-pdf\/29\/5\/pyag021\/68194209\/pyag021.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ijnp\/article-pdf\/29\/5\/pyag021\/68194209\/pyag021.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:52:19Z","timestamp":1779378739000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijnp\/article\/doi\/10.1093\/ijnp\/pyag021\/8665612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ijnp\/pyag021","relation":{},"ISSN":["1461-1457","1469-5111"],"issn-type":[{"value":"1461-1457","type":"print"},{"value":"1469-5111","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,4,30]]},"article-number":"pyag021"}}